A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer (Q44233646)
Jump to navigation
Jump to search
scientific article published in May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer |
scientific article published in May 2014 |
Statements
1 reference
A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer (English)
1 reference
Klaus Sahora
Martin Schindl
Irene Kuehrer
Axel Eisenhut
Gregor Werba
Bela Telek
1 May 2014
1 reference